Published on
January 16, 2017
- 20:38 GMT
FDA GRANTS ORPHAN-DRUG DESIGNATION TO AN ORAL LIQUID SUSPENSION OF CELECOXIB TO TREAT ARTHRITIS IN CHILDREN
FDA grants orphan-drug designation for NuBioPharma,LLC's Nu-Celecoxib™ (celecoxib) an oral liquid suspension to treat pediatric juvenile idiopathic arthritis. SANFORD, NORTH CAROLINA, UNITED STATES, January 16, 2017 /EINPresswire.com/ -- Sanford, NC; …
Distribution channels:
Healthcare & Pharmaceuticals Industry
